In the wake of shortages caused by Hurricane Maria, half a dozen groups that represent hospitals, doctors, and pharmacists are urging Congress to examine the lack of information provided by drug makers about product supplies.

The storm has caused shortages of various medicines — notably, solutions such as saline — but the extent to which manufacturing for many other drugs has been disrupted remains unclear. That’s because federal and state laws do not require companies to disclose which products are made at which plants.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy